Health

Emails Point to ‘Troubling’ Relationship Between Drug Firms, Regulators

[Milwaukee Wisconsin Journal Sentinel]

Hydrocodone-paracetamol-5-500

Federal health industry regulators and executives of companies that make pain drugs have held private meetings at expensive hotels at least once a year since 2002 through an organization funded by the drug companies, according to emails obtained through public records requests and provided to the Journal Sentinel/MedPage Today.

Each year a handful of drug companies have paid up to $35,000 each to send a representative to meetings of IMMPACT, where they could discuss clinical trial testing procedures with officials from the U.S. Food and Drug Administration and other government agencies. IMMPACT’s stated goal is to improve the design of clinical trials conducted to develop new pain treatments.

The emails raise concerns about a pay-for-play arrangement in which drug companies were able to buy access to invitation-only meetings where they could meet with FDA officials and affect FDA pain drug policy, said Michael Carome, director of health research for the watchdog group Public Citizen.

“The whole picture is a troubling one and it warrants an independent investigation,” said Carome, who has seen the emails.

Tags
Show More

Related Articles

Back to top button

Subscribe today for free and be the first to have news and information delivered directly to your inbox.


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Adblock Detected

Please consider supporting us by disabling your ad blocker
%d bloggers like this: